The ABPI and Northern Ireland’s Medicines Optimisation Innovation Centre have announced a new partnership to deliver ‘triple win’ benefits to patients, NI HSC and the economy.
The UK has been leading the rest of Europe in early-stage clinical research according to new data published by the ABPI in its second annual report on the state of clinical trials in the UK.
The Chief Executive of the UK’s pharmaceutical industry association has today warned MPs about the consequences of not agreeing a comprehensive post-Brexit trade deal or an urgent agreement on medicines while the trade talks continue.
The NHS Confederation has today published two reports - NHS Reset: A new direction for health and care and Health Inequalities: Time to act.
The UK and EU pharmaceutical industry are today jointly asking the UK Government and the European Commission to prioritise medicines in trade talks.
The Department of Health and Social Care has published its National Genomic Healthcare Strategy, which sets out their aim to cement the UK as a global leader in genomics.
“Pharmaceutical companies have done everything in their power to prepare for a ‘no deal’ Brexit. This includes increasing stocks of medicines, changing and adding new supply routes and duplicating manufacturing processes here and in Europe."
The UK and Japan have reached an agreement on the terms of a future trade deal. This will allow pharmaceutical companies in the UK to continue trading largely as they do now come 1 January 2021.
The MHRA has published information for pharmaceutical companies preparing for the end of the Brexit transition period.
The Health Secretary has announced that Public Health England is to be replaced with a new body called the National Institute for Health Protection, in a merger of the pandemic response work of PHE and NHS Test and Trace.